MANE
Income statement / Annual
Last year (2024), Veradermics Inc's total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2024, Veradermics Inc's net income was -$26.49 M.
See Veradermics Inc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
| Period Ended |
12/31/2024 |
12/31/2023 |
| Operating Revenue |
$0.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$0.00
|
| Gross Profit |
$0.00
|
$0.00
|
| Gross Profit Ratio |
0
|
0
|
| Research and Development Expenses |
$23.28 M
|
$14.97 M
|
| General & Administrative Expenses |
$3.50 M
|
$2.35 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$3.50 M
|
$2.35 M
|
| Other Expenses |
$0.00
|
$0.00
|
| Operating Expenses |
$26.78 M
|
$17.32 M
|
| Cost And Expenses |
$26.78 M
|
$17.32 M
|
| Interest Income |
$481.00 K
|
$870.00 K
|
| Interest Expense |
$585.00 K
|
$36.00 K
|
| Depreciation & Amortization |
$0.00
|
$0.00
|
| EBITDA |
-$25.90 M |
-$16.45 M |
| EBITDA Ratio |
0
|
0
|
| Operating Income Ratio |
0
|
0
|
| Total Other Income/Expenses Net |
$290.00 K
|
$834.00 K
|
| Income Before Tax |
-$26.49 M
|
-$16.49 M
|
| Income Before Tax Ratio |
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
| Net Income |
-$26.49 M
|
-$16.49 M
|
| Net Income Ratio |
0
|
0
|
| EPS |
-0.14 |
-0.0819 |
| EPS Diluted |
-0.14 |
-0.0819 |
| Weighted Average Shares Out |
$201.33 M
|
$201.33 M
|
| Weighted Average Shares Out Diluted |
$201.33 M
|
$201.33 M
|
| Link |
|
|
